<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns="http://www.w3.org/TR/REC-html40">


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Pyridostigminbromid.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:07:09 GMT -->
<head>
<meta http-equiv=Content-Type content="text/html; charset=windows-1252">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 11">
<meta name=Originator content="Microsoft Word 11">
<link rel=File-List href="javascript:if(confirm('http://www.vietstarse.com/duocthu/Documents/Pyridostigminbromid_files/filelist.xml  \n\nThis file was not retrieved by Teleport Pro, because the server reports that this file cannot be found.  \n\nDo you want to open it from the server?'))window.location='http://www.vietstarse.com/duocthu/Documents/Pyridostigminbromid_files/filelist.xml'" tppabs="http://www.vietstarse.com/duocthu/Documents/Pyridostigminbromid_files/filelist.xml">
<title>PYRIDOSTIGMIN BROMID</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>VIETSTAR</o:Author>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>lylv</o:LastAuthor>
  <o:Revision>3</o:Revision>
  <o:TotalTime>1</o:TotalTime>
  <o:Created>2006-07-30T16:56:00Z</o:Created>
  <o:LastSaved>2006-08-01T07:35:00Z</o:LastSaved>
  <o:Pages>2</o:Pages>
  <o:Words>1443</o:Words>
  <o:Characters>8227</o:Characters>
  <o:Company>VS</o:Company>
  <o:Lines>68</o:Lines>
  <o:Paragraphs>19</o:Paragraphs>
  <o:CharactersWithSpaces>9651</o:CharactersWithSpaces>
  <o:Version>11.5606</o:Version>
 </o:DocumentProperties>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:DoNotHyphenateCaps/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas>false</w:ValidateAgainstSchemas>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotUnderlineInvalidXML/>
  <w:Compatibility>
   <w:SelectEntireFieldWithStartOrEnd/>
   <w:UseWord2002TableStyleRules/>
  </w:Compatibility>
  <w:BrowserLevel>MicrosoftInternetExplorer4</w:BrowserLevel>
 </w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" LatentStyleCount="156">
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1627421319 -2147483648 8 0 66047 0;}
@font-face
	{font-family:TahomaH;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:Arial;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-parent:"";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
h1
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-font-kerning:0pt;}
h2
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:9.0pt;
	font-family:Tahoma;}
h3
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	layout-grid-mode:char;
	font-size:14.0pt;
	font-family:Tahoma;
	font-weight:normal;
	font-style:italic;}
h4
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	font-size:9.0pt;
	font-family:Tahoma;
	font-weight:normal;}
h5
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:5;
	font-size:9.0pt;
	font-family:Tahoma;}
h6
	{mso-style-next:Normal;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.3pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:6;
	font-size:9.0pt;
	font-family:Tahoma;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:7;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:8;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-next:Normal;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:9;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:right 411.1pt;
	border:none;
	mso-border-bottom-alt:solid windowtext .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 1.0pt 0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.0in right 6.0in;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
span.MsoFootnoteReference
	{mso-style-noshow:yes;
	vertical-align:super;}
span.MsoCommentReference
	{mso-style-noshow:yes;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
span.MsoPageNumber
	{mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:Tahoma;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:TahomaH;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TahomaH;
	font-weight:bold;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-2.0in;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:14.2pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	margin-bottom:.0001pt;
	text-align:justify;
	text-indent:-14.15pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	punctuation-wrap:simple;
	text-autospace:none;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	background:navy;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.1, li.1, div.1
	{mso-style-name:1;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.1nho, li.1nho, div.1nho
	{mso-style-name:1nho;
	margin-top:3.5pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.3, li.3, div.3
	{mso-style-name:3;
	mso-style-parent:2;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.5, li.5, div.5
	{mso-style-name:5;
	mso-style-parent:2;
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:8.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-style:italic;}
p.bai, li.bai, div.bai
	{mso-style-name:bai;
	mso-style-parent:"Heading 2";
	margin-top:25.0pt;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	text-align:center;
	line-height:10.4pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:10.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.BodyText21, li.BodyText21, div.BodyText21
	{mso-style-name:"Body Text 21";
	margin:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	mso-line-height-alt:10.5pt;
	mso-pagination:widow-orphan;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";}
p.cach0, li.cach0, div.cach0
	{mso-style-name:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.chucach, li.chucach, div.chucach
	{mso-style-name:chucach;
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.normal1, li.normal1, div.normal1
	{mso-style-name:normal1;
	mso-style-parent:"cach0\,4";
	margin-top:4.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	margin-bottom:.0001pt;
	text-align:justify;
	line-height:10.5pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;}
p.Style1, li.Style1, div.Style1
	{mso-style-name:Style1;
	mso-style-parent:"Heading 2";
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:48.2pt;
	text-align:justify;
	text-indent:-17.0pt;
	line-height:150%;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:list 49.2pt;
	font-size:14.0pt;
	font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
@page Section1
	{size:8.5in 11.0in;
	margin:1.0in 1.25in 1.0in 1.25in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.Section1
	{page:Section1;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-para-margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman";
	mso-ansi-language:#0400;
	mso-fareast-language:#0400;
	mso-bidi-language:#0400;}
</style>
<![endif]-->
</head>

<body lang=EN-US style='tab-interval:.5in'>

<div class=Section1>

<h1 align=center style='text-align:center;line-height:150%'><span
style='font-family:Verdana'>PYRIDOSTIGMIN BROMID<o:p></o:p></span></h1>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='font-family:Verdana'>Tên chung qu&#7889;c t&#7871;: </span></b><span
style='font-family:Verdana'>Pyridostigmine bromide.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='font-family:Verdana'>Mã ATC</span></b><span style='font-family:Verdana'>:
N07A A02.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><b><span
style='font-family:Verdana'>Lo&#7841;i thu&#7889;c</span></b><span
style='font-family:Verdana'>: Thu&#7889;c gi&#7889;ng th&#7847;n kinh &#273;&#7889;i
giao c&#7843;m, thu&#7889;c ch&#7889;ng nh&#432;&#7907;c c&#417;.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='font-family:Verdana'>D&#7841;ng thu&#7889;c và hàm l&#432;&#7907;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>&#7888;ng tiêm 2 ml (5 mg/ml; Siro 60 mg/5 ml; viên
nén 60 mg; viên nén gi&#7843;i phóng kéo dài 180 mg (60 mg &#273;&#432;&#7907;c
gi&#7843;i phóng ngay l&#7853;p t&#7913;c và 120 mg gi&#7843;i phóng sau 8 - 12
gi&#7901;).<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='font-family:Verdana'>D&#432;&#7907;c lý và c&#417; ch&#7871;
tác d&#7909;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Pyridostigmin bromid là m&#7897;t h&#7907;p ch&#7845;t
amoni b&#7853;c b&#7889;n gây &#7913;c ch&#7871; ho&#7841;t tính enzym
cholinesterase có tác d&#7909;ng gi&#7889;ng neostigmin, nh&#432;ng tác d&#7909;ng
xu&#7845;t hi&#7879;n ch&#7853;m và kéo dài h&#417;n, vì th&#7871; thu&#7889;c
&#273;&#432;&#7907;c dùng ch&#7911; y&#7871;u trong &#273;i&#7873;u tr&#7883; b&#7879;nh
nh&#432;&#7907;c c&#417;. Kho&#7843;ng cách gi&#7919;a các li&#7873;u c&#7911;a
pyridostigmin dài h&#417;n so v&#7899;i neostigmin, t&#7841;o thu&#7853;n l&#7907;i
trong &#273;i&#7873;u tr&#7883; b&#7879;nh nh&#432;&#7907;c c&#417;. Vì th&#7871;
có th&#7875; k&#7871;t h&#7907;p pyridostigmin v&#7899;i neostigmin trong
&#273;i&#7873;u tr&#7883; b&#7879;nh nh&#432;&#7907;c c&#417;, thí d&#7909;
dùng pyridostigmin trong ngày và t&#7889;i, neostigmin dùng vào bu&#7893;i
sáng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Thu&#7889;c gây &#273;áp &#7913;ng cholinergic toàn
thân bao g&#7891;m t&#259;ng tr&#432;&#417;ng l&#7921;c c&#417; x&#432;&#417;ng
và c&#417; ru&#7897;t, co &#273;&#7891;ng t&#7917;, co th&#7855;t t&#7917;
cung, co th&#7855;t ph&#7871; qu&#7843;n, ch&#7853;m nh&#7883;p tim, t&#259;ng
ti&#7871;t &#7903; các tuy&#7871;n ngo&#7841;i ti&#7871;t. Pyridostigmin có tác
d&#7909;ng gi&#7889;ng cholin tr&#7921;c ti&#7871;p trên c&#417; x&#432;&#417;ng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Pyridostigmin &#273;&#432;&#7907;c h&#7845;p thu
ít, v&#7899;i t&#7927; l&#7879; thay &#273;&#7893;i, qua &#273;&#432;&#7901;ng
tiêu hóa; ch&#7881; kho&#7843;ng 40% li&#7873;u u&#7889;ng pyridos-<br>
tigmin &#273;&#432;&#7907;c h&#7845;p thu, m&#7897;t l&#432;&#7907;ng l&#7899;n
b&#7883; phá h&#7911;y &#7903; d&#7841; dày ru&#7897;t. Pyridostigmin
&#273;&#432;&#7907;c h&#7845;p thu nhi&#7873;u nh&#7845;t &#7903; tá tràng. B&#7883;
th&#7911;y phân b&#7903;i cholinesterase và c&#361;ng b&#7883; chuy&#7875;n hóa
&#7903; gan. Pyridostigmin &#273;&#432;&#7907;c &#273;ào th&#7843;i ch&#7911; y&#7871;u
qua n&#432;&#7899;c ti&#7875;u (&#7903; c&#7843; d&#7841;ng không &#273;&#7893;i
và d&#7841;ng b&#7883; chuy&#7875;n hóa). M&#7897;t ph&#7847;n r&#7845;t nh&#7887;
&#273;&#432;&#7907;c th&#7843;i qua s&#7919;a.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Pyridostigmin phân b&#7889; &#7903; d&#7883;ch ngo&#7841;i
bào. Thu&#7889;c không vào &#273;&#432;&#7907;c h&#7879; th&#7847;n kinh trung
&#432;&#417;ng. Thu&#7889;c qua nhau thai và làm gi&#7843;m ho&#7841;t tính
cholinesterase huy&#7871;t t&#432;&#417;ng thai nhi sau khi u&#7889;ng thu&#7889;c
li&#7873;u cao.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Khi u&#7889;ng, thu&#7889;c th&#432;&#7901;ng có
tác d&#7909;ng sau 30 - 45 phút và kéo dài trong 3 - 6 gi&#7901;. Khi tiêm t&#297;nh
m&#7841;ch, l&#7921;c c&#417; t&#259;ng lên sau 2 - 5 phút và s&#7921; c&#7843;i
thi&#7879;n có th&#7875; ti&#7871;p t&#7909;c trong 2 - 3 gi&#7901; &#7903; ph&#7847;n
l&#7899;n ng&#432;&#7901;i b&#7879;nh. Sau khi tiêm b&#7855;p, thu&#7889;c b&#7855;t
&#273;&#7847;u có tác d&#7909;ng trong vòng 15 phút.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>N&#7917;a &#273;&#7901;i th&#7843;i tr&#7915; c&#7911;a
thu&#7889;c là 1,49 gi&#7901; &#273;&#7889;i v&#7899;i tiêm b&#7855;p và 1,5 -
4,25 gi&#7901;, khi u&#7889;ng.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='font-family:Verdana'>Ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Pyridostigmin &#273;&#432;&#7907;c s&#7917; d&#7909;ng
trong &#273;i&#7873;u tr&#7883; b&#7879;nh nh&#432;&#7907;c c&#417;, nh&#432; m&#7897;t
thu&#7889;c &#273;&#7843;o ngh&#7883;ch ho&#7863;c &#273;&#7889;i kháng v&#7899;i
các thu&#7889;c giãn c&#417; không kh&#7917; c&#7921;c ki&#7875;u cura.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='font-family:Verdana'>Ch&#7889;ng ch&#7881; &#273;&#7883;nh<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Ch&#7889;ng ch&#7881; &#273;&#7883;nh dùng
pyridostigmin &#7903; ng&#432;&#7901;i &#273;ã bi&#7871;t có quá m&#7851;n v&#7899;i
các thu&#7889;c kháng cholinesterase, ho&#7863;c &#7903; ng&#432;&#7901;i t&#7855;c
ru&#7897;t và t&#7855;c &#273;&#432;&#7901;ng ti&#7871;t ni&#7879;u ki&#7875;u
c&#417; h&#7885;c.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='font-family:Verdana'>Th&#7853;n tr&#7885;ng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>C&#7847;n dùng th&#7853;n tr&#7885;ng pyridostigmin
&#7903; ng&#432;&#7901;i &#273;&#7897;ng kinh, hen ph&#7871; qu&#7843;n, nh&#7883;p
tim ch&#7853;m, m&#7899;i t&#7855;c m&#7841;ch vành, c&#432;&#7901;ng &#273;&#7889;i
giao c&#7843;m, c&#432;&#7901;ng tuy&#7871;n giáp, lo&#7841;n nh&#7883;p tim ho&#7863;c
loét d&#7841; dày. Tránh u&#7889;ng li&#7873;u l&#7899;n &#7903; nh&#7919;ng
ng&#432;&#7901;i m&#7855;c ch&#7913;ng ru&#7897;t k&#7871;t to ho&#7863;c gi&#7843;m
nhu &#273;&#7897;ng d&#7841; dày - ru&#7897;t.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>&#7902; m&#7897;t s&#7889; ng&#432;òi,
pyridostigmin bromid kéo dài tác d&#7909;ng h&#417;n mu&#7889;i c&#7911;a
neostigmin, trong nh&#7919;ng tr&#432;&#7901;ng h&#7907;p nh&#432; v&#7853;y
th&#432;&#7901;ng hay gây các c&#417;n t&#259;ng ti&#7871;t acetyl-cholin.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Khi s&#7917; d&#7909;ng pyridostigmin &#273;&#7875;
&#273;i&#7873;u tr&#7883; b&#7879;nh nh&#432;&#7907;c c&#417;, c&#7847;n nh&#7899;
r&#7857;ng, v&#7899;i cùng m&#7897;t li&#7873;u thu&#7889;c kháng
cholines-terase, có th&#7875; có nh&#7919;ng &#273;áp &#7913;ng khác nhau &#7903;
nh&#7919;ng nhóm c&#417; riêng bi&#7879;t: gây y&#7871;u &#7903; m&#7897;t nhóm
c&#417; này trong khi &#273;ó l&#7841;i làm t&#259;ng l&#7921;c c&#417; &#7903;
nhóm khác. Nh&#7919;ng c&#417; &#7903; c&#7893; và các c&#417; nhai và nu&#7889;t
th&#432;&#7901;ng là nhóm c&#417; &#273;&#7847;u tiên b&#7883; y&#7871;u
&#273;i khi dùng thu&#7889;c quá li&#7873;u. Ph&#7843;i &#273;o dung tích s&#7889;ng
b&#7845;t c&#7913; khi nào t&#259;ng li&#7873;u &#273;&#7875; có th&#7875;
&#273;i&#7873;u ch&#7881;nh li&#7873;u thu&#7889;c kháng cholinesterase nh&#7857;m
&#273;&#7843;m b&#7843;o t&#7889;t ch&#7913;c n&#259;ng hô h&#7845;p.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Pyridostigmin qua &#273;&#432;&#7907;c nhau thai và
bài ti&#7871;t vào s&#7919;a m&#7865;, vì th&#7871; ph&#7843;i s&#7917; d&#7909;ng
th&#7853;n tr&#7885;ng &#273;&#7889;i v&#7899;i ng&#432;&#7901;i mang thai và
cho con bú.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>S&#7917; d&#7909;ng thu&#7889;c có tác d&#7909;ng
ch&#7889;ng ti&#7871;t cholin ho&#7863;c tác d&#7909;ng gi&#7889;ng nh&#432;
atropin ph&#7843;i h&#7871;t s&#7913;c c&#7849;n th&#7853;n, khi ng&#432;&#7901;i
b&#7879;nh c&#361;ng &#273;&#432;&#7907;c &#273;i&#7873;u tr&#7883; b&#7857;ng
pyridostigmin vì các tri&#7879;u ch&#7913;ng quá li&#7873;u có th&#7875; b&#7883;
che l&#7845;p b&#7903;i pyridos-tigmin, ho&#7863;c ng&#432;&#7907;c l&#7841;i,
các tri&#7879;u ch&#7913;ng dùng pyridos-tigmin quá li&#7873;u c&#361;ng có th&#7875;
b&#7883; che l&#7845;p b&#7903;i atropin và các thu&#7889;c gi&#7889;ng
atropin.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='font-family:Verdana'>Th&#7901;i k&#7923; mang thai<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Tính an toàn c&#7911;a pyridostigmin &#7903;
ng&#432;&#7901;i mang thai v&#7851;n ch&#432;a &#273;&#432;&#7907;c xác &#273;&#7883;nh,
nh&#432;ng nh&#7919;ng thu&#7889;c kháng cholinesterase có th&#7875; gây kích
thích t&#7917; cung và gây &#273;&#7867; non khi tiêm t&#297;nh m&#7841;ch cho
ng&#432;&#7901;i mang thai g&#7847;n k&#7923; sinh. Tuy nhiên, pyridostigmin
&#273;ã &#273;&#432;&#7907;c s&#7917; d&#7909;ng trong thai k&#7923; mà không
gây d&#7883; d&#7841;ng cho thai.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Ðã quan sát &#273;&#432;&#7907;c y&#7871;u c&#417;
t&#7841;m th&#7901;i &#7903; kho&#7843;ng 10 - 20% tr&#7867; s&#417; sinh, do m&#7865;
&#273;ã dùng thu&#7889;c kháng cholinesterase &#273;&#7875; &#273;i&#7873;u tr&#7883;
b&#7879;nh nh&#432;&#7907;c c&#417;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Vì v&#7853;y, vi&#7879;c s&#7917; d&#7909;ng
pyridostigmin cho ng&#432;&#7901;i mang thai c&#7847;n ph&#7843;i cân nh&#7855;c
gi&#7919;a l&#7907;i ích và nguy h&#7841;i cho m&#7865; và con.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='font-family:Verdana'>Th&#7901;i k&#7923; cho con bú<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Pyridostigmin bài ti&#7871;t m&#7897;t ph&#7847;n
vào s&#7919;a m&#7865;, vì v&#7853;y không nên dùng khi cho con bú.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='font-family:Verdana'>Tác d&#7909;ng không mong mu&#7889;n
(ADR)<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Tác d&#7909;ng không mong mu&#7889;n hay g&#7863;p
nh&#7845;t là nôn. Tác d&#7909;ng không mong mu&#7889;n th&#432;&#7901;ng liên
quan t&#7899;i quá li&#7873;u và th&#432;&#7901;ng thu&#7897;c 2 ki&#7875;u:
Các tri&#7879;u ch&#7913;ng gi&#7889;ng muscarin, và các tri&#7879;u ch&#7913;ng
gi&#7889;ng nicotin.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Tri&#7879;u ch&#7913;ng chính c&#7911;a quá li&#7873;u
trong tr&#432;&#7901;ng h&#7907;p b&#7879;nh nh&#432;&#7907;c c&#417; là làm
t&#259;ng y&#7871;u c&#417;.<o:p></o:p></span></p>

<h2 align=left style='margin-top:0in;text-align:left;line-height:150%'><i><span
style='font-family:Verdana;font-weight:normal'>Th&#432;&#7901;ng g&#7863;p, ADR
&gt; 1/100<o:p></o:p></span></i></h2>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Toàn thân: T&#259;ng ti&#7871;t m&#7891; hôi, chán
&#259;n.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Tu&#7847;n hoàn: Nh&#7883;p tim ch&#7853;m,
nh&#432;ng th&#7881;nh tho&#7843;ng l&#7841;i nh&#7883;p tim nhanh.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Tiêu hóa: Bu&#7891;n nôn, nôn, &#7881;a ch&#7843;y,
t&#259;ng nhu &#273;&#7897;ng, &#273;au b&#7909;ng, ti&#7871;t n&#432;&#7899;c
b&#7885;t.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Hô h&#7845;p: T&#259;ng ti&#7871;t d&#7883;ch, co
th&#7855;t ph&#7871; qu&#7843;n, viêm m&#361;i.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Th&#7847;n kinh: Y&#7871;u c&#417;, li&#7879;t nh&#7865;,
co gi&#7853;t, co c&#7913;ng c&#417; c&#7909;c b&#7897;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Ti&#7871;t ni&#7879;u - sinh d&#7909;c: Ti&#7875;u
ti&#7879;n không ch&#7911; &#273;&#7897;ng.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>M&#7855;t: Co &#273;&#7891;ng t&#7917;, t&#259;ng
ti&#7871;t n&#432;&#7899;c m&#7855;t, m&#7901; m&#7855;t, viêm k&#7871;t m&#7841;c.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='font-family:Verdana'>Ít g&#7863;p, 1/1000 &lt; ADR &lt; 1/100<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Toàn thân: Chóng m&#7863;t.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Tu&#7847;n hoàn: T&#259;ng huy&#7871;t áp ho&#7863;c
h&#7841; huy&#7871;t áp.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Th&#7847;n kinh trung &#432;&#417;ng: Thao th&#7913;c,
m&#7845;t ng&#7911;.<o:p></o:p></span></p>

<h2 align=left style='margin-top:0in;text-align:left;line-height:150%'><i><span
style='font-family:Verdana;font-weight:normal'>Hi&#7871;m g&#7863;p, ADR &lt;
1/1000<o:p></o:p></span></i></h2>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Da: Ngo&#7841;i ban, r&#7909;ng tóc. <o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='font-family:Verdana'>Li&#7873;u l&#432;&#7907;ng và cách
dùng<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='font-family:Verdana'>Cách dùng: </span></i><span style='font-family:
Verdana'>Pyridostigmin bromid có th&#7875; u&#7889;ng ho&#7863;c tiêm b&#7855;p
ho&#7863;c tiêm t&#297;nh m&#7841;ch r&#7845;t ch&#7853;m.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='font-family:Verdana'>Li&#7873;u l&#432;&#7907;ng:</span></i><span
style='font-family:Verdana'> B&#7879;nh nh&#432;&#7907;c c&#417;: Li&#7873;u
l&#432;&#7907;ng có th&#7875; thay &#273;&#7893;i t&#7915;ng ngày, tùy theo b&#7879;nh
&#273;&#7905; hay n&#7863;ng lên, stress v&#7873; c&#7843;m xúc và th&#7875; l&#7921;c
c&#7911;a ng&#432;&#7901;i b&#7879;nh. Li&#7873;u ph&#7843;i &#273;i&#7873;u ch&#7881;nh
&#273;&#7875; ng&#432;&#7901;i b&#7879;nh dùng li&#7873;u cao lúc ph&#7843;i g&#7855;ng
s&#7913;c nhi&#7873;u nh&#7845;t (thí d&#7909; 30 - 45 phút tr&#432;&#7899;c
khi &#259;n &#273;&#7875; giúp ng&#432;&#7901;i b&#7879;nh khi khó nu&#7889;t).
Pyridogtigmin u&#7889;ng cùng v&#7899;i s&#7919;a ho&#7863;c th&#7913;c &#259;n
gây ít tác d&#7909;ng ph&#7909; muscarinic.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='font-family:Verdana'>D&#7841;ng u&#7889;ng (siro và viên nén)<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Ði&#7873;u tr&#7883; b&#7879;nh nh&#432;&#7907;c
c&#417;: <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Ng&#432;&#7901;i l&#7899;n và thi&#7871;u niên:
Tr&#432;&#7899;c h&#7871;t dùng li&#7873;u 30 &#273;&#7871;n 60 mg, cách 3
&#273;&#7871;n 4 gi&#7901; m&#7897;t l&#7847;n. Sau &#273;ó, li&#7873;u duy trì
t&#7915; 60 mg &#273;&#7871;n 1200 mg m&#7895;i ngày (th&#432;&#7901;ng dùng
600 mg).<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Tr&#7867; em: T&#7893;ng li&#7873;u hàng ngày
th&#432;&#7901;ng là 7 mg/kg th&#7875; tr&#7885;ng (ho&#7863;c 200 mg/m<sup>2</sup>
di&#7879;n tích c&#417; th&#7875;) chia làm 5 ho&#7863;c 6 l&#7847;n. Có th&#7875;
dùng li&#7873;u &#273;&#7847;u tiên là 30 mg cho tr&#7867; d&#432;&#7899;i 6 tu&#7893;i
ho&#7863;c 60 mg cho tr&#7867; 6 - 12 tu&#7893;i. Li&#7873;u này &#273;&#432;&#7907;c
t&#259;ng thêm d&#7847;n 15 - 30 mg hàng ngày, cho &#273;&#7871;n khi &#273;&#7841;t
&#273;&#432;&#7907;c hi&#7879;u qu&#7843; mong mu&#7889;n, nh&#432;ng t&#7893;ng
li&#7873;u không v&#432;&#7907;t quá 360 mg/ngày.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='font-family:Verdana'>D&#7841;ng u&#7889;ng, tác d&#7909;ng kéo dài (viên
nén gi&#7843;i phóng ho&#7841;t ch&#7845;t t&#7915; t&#7915;)<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Ði&#7873;u tr&#7883; b&#7879;nh nh&#432;&#7907;c
c&#417; n&#7863;ng:<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Ng&#432;&#7901;i l&#7899;n và thi&#7871;u niên: 180
mg &#273;&#7871;n 540 mg/l&#7847;n; 1 ho&#7863;c 2 l&#7847;n/ngày, cách nhau ít
nh&#7845;t 6 gi&#7901;.<o:p></o:p></span></p>

<h2 align=left style='margin-top:0in;text-align:left;line-height:150%'><i><span
style='font-family:Verdana;font-weight:normal'>D&#7841;ng tiêm<o:p></o:p></span></i></h2>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Ng&#432;&#7901;i l&#7899;n và thi&#7871;u niên: 2
mg/l&#7847;n; tiêm b&#7855;p ho&#7863;c t&#297;nh m&#7841;ch, cách 2 - 4 gi&#7901;
m&#7897;t l&#7847;n (x&#7845;p x&#7881; 1/30 c&#7911;a li&#7873;u u&#7889;ng
th&#432;&#7901;ng dùng).<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Tr&#7867; em: 50 &#273;&#7871;n 150 microgam/kg th&#7875;
tr&#7885;ng, tiêm b&#7855;p 4 &#273;&#7871;n 6 gi&#7901; m&#7897;t l&#7847;n.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>B&#7879;nh nh&#432;&#7907;c c&#417; &#7903; tr&#7867;
s&#417; sinh: Neostigmin th&#432;&#7901;ng &#273;&#432;&#7907;c &#432;a dùng
h&#417;n, tuy pyridostigmin c&#361;ng &#273;ã &#273;&#432;&#7907;c dùng. Li&#7873;u
t&#7915; 50 - 150 microgam/kg, tiêm b&#7855;p ho&#7863;c 5 - 10 mg u&#7889;ng
cách 4 - 6 gi&#7901;/l&#7847;n. ít khi ph&#7843;i &#273;i&#7873;u tr&#7883; quá
8 tu&#7847;n tu&#7893;i.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='font-family:Verdana'>Ghi chú:</span></i><span style='font-family:Verdana'>
Trên th&#7921;c t&#7871;, chúng ta có th&#7875; s&#7917; d&#7909;ng dung d&#7883;ch
pyridostigmin 0,25% - 0,5% &#273;&#7875; kích thích ru&#7897;t khi b&#7883; li&#7879;t
ru&#7897;t sau ph&#7851;u thu&#7853;t (tiêm d&#432;&#7899;i da, 1 - 3 &#7889;ng/ngày;
&#7889;ng 1 ml; 0,1%).<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Ð&#7889;i kháng thu&#7889;c giãn c&#417; không kh&#7917;
c&#7921;c:<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Li&#7873;u t&#7915; 10 &#273;&#7871;n 20 mg, tiêm t&#297;nh
m&#7841;ch ch&#7853;m (0,1 - 0,25 mg/kg). Tr&#432;&#7899;c &#273;ó, tiêm t&#297;nh
m&#7841;ch atropin sulfat 0,6 - 1,2 mg &#273;&#7875; ch&#7889;ng l&#7841;i b&#7845;t
c&#7913; tác d&#7909;ng muscarinic nào.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='font-family:Verdana'>T&#432;&#417;ng tác thu&#7889;c <o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Pyridostigmin dùng &#273;&#432;&#7901;ng tiêm
&#273;&#7889;i kháng m&#7897;t cách hi&#7879;u qu&#7843; tác d&#7909;ng c&#7911;a
các thu&#7889;c giãn c&#417; không kh&#7917; c&#7921;c (nh&#432; tubocurarin,
metocurin, galamin, ho&#7863;c pancuronium), và t&#432;&#417;ng tác này
&#273;&#432;&#7907;c s&#7917; d&#7909;ng có l&#7907;i trong &#273;i&#7873;u tr&#7883;
nh&#7857;m &#273;&#7843;o ngh&#7883;ch s&#7921; giãn c&#417; sau ph&#7851;u thu&#7853;t.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Atropin &#273;&#7889;i kháng v&#7899;i tác d&#7909;ng
muscarinic c&#7911;a pyridostigmin, và t&#432;&#417;ng tác này &#273;&#432;&#7907;c
s&#7917; d&#7909;ng &#273;&#7875; ch&#7889;ng các tác d&#7909;ng muscarinic khi
ng&#7897; &#273;&#7897;c pyridostigmin.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Dexpanthenol có th&#7875; hi&#7879;p &#273;&#7891;ng
tác d&#7909;ng v&#7899;i pyridostigmin b&#7857;ng cách t&#259;ng s&#7843;n xu&#7845;t
acetylcholin.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Các thu&#7889;c kháng cholinesterase &#273;ôi khi
có hi&#7879;u l&#7921;c &#273;&#7875; &#273;&#7843;o ngh&#7883;ch s&#7921; ch&#7865;n
th&#7847;n kinh - c&#417; do các kháng sinh aminoglycosid gây ra. Tuy nhiên các
kháng sinh aminoglycosid, các thu&#7889;c tê và m&#7897;t s&#7889; thu&#7889;c
mê, thu&#7889;c ch&#7889;ng lo&#7841;n nh&#7883;p, các thu&#7889;c gây c&#7843;n
tr&#7903; d&#7851;n truy&#7873;n th&#7847;n kinh c&#417; ph&#7843;i
&#273;&#432;&#7907;c s&#7917; d&#7909;ng th&#7853;n tr&#7885;ng &#7903;
ng&#432;&#7901;i nh&#432;&#7907;c c&#417; n&#7863;ng, và li&#7873;u c&#7911;a
pyridostigmin có th&#7875; ph&#7843;i t&#259;ng lên sao cho phù h&#7907;p.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='font-family:Verdana'>Ð&#7897; &#7893;n &#273;&#7883;nh và b&#7843;o
qu&#7843;n<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>B&#7843;o qu&#7843;n d&#432;&#7899;i 40<sup>o</sup>C,
t&#7889;t nh&#7845;t &#7903; kho&#7843;ng 15 - 30<sup>o</sup>C, b&#7843;o qu&#7843;n
kín. Tránh xa t&#7847;m v&#7899;i c&#7911;a tr&#7867; em, tránh nóng và ánh
sáng tr&#7921;c ti&#7871;p. Không &#273;&#7875; thu&#7889;c tiêm và siro
&#273;ông b&#259;ng.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='font-family:Verdana'>T&#432;&#417;ng k&#7925;<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Tránh dùng pyridostigmin và atropin trong cùng m&#7897;t
b&#417;m tiêm.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='font-family:Verdana'>Quá li&#7873;u và x&#7917; trí<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='font-family:Verdana'>D&#7845;u hi&#7879;u và các tri&#7879;u ch&#7913;ng
c&#7911;a quá li&#7873;u (c&#417;n t&#259;ng ti&#7871;t acetylcholin)<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Tác d&#7909;ng muscarinic: Ðau qu&#7863;n b&#7909;ng,
t&#259;ng nhu &#273;&#7897;ng ru&#7897;t, &#7881;a ch&#7843;y, bu&#7891;n nôn,
nôn, t&#259;ng ti&#7871;t n&#432;&#7899;c b&#7885;t và d&#7883;ch ph&#7871; qu&#7843;n,
toát m&#7891; hôi, co &#273;&#7891;ng t&#7917;.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Tác d&#7909;ng nicotinic: Y&#7871;u c&#417;, co c&#7913;ng
c&#417; c&#7909;c b&#7897; và chu&#7897;t rút.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Th&#7847;n kinh trung &#432;&#417;ng: Kích &#273;&#7897;ng,
thao th&#7913;c, m&#7845;t ph&#7843;n x&#7841;, nói líu nhíu.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Tu&#7847;n hoàn: Ch&#7853;m nh&#7883;p tim, h&#7841;
huy&#7871;t áp, ng&#7915;ng tim.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Tiêu hóa: Các tri&#7879;u ch&#7913;ng tiêu hóa x&#7843;y
ra s&#7899;m nh&#7845;t sau khi u&#7889;ng thu&#7889;c: chán &#259;n, bu&#7891;n
nôn, nôn, chu&#7897;t rút b&#7909;ng, &#7881;a ch&#7843;y.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><i><span
style='font-family:Verdana'>Ði&#7873;u tr&#7883;:<o:p></o:p></span></i></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Ng&#7915;ng thu&#7889;c ngay l&#7853;p t&#7913;c.
Nh&#7919;ng tác d&#7909;ng muscarinic là n&#7863;ng nh&#7845;t và có th&#7875;
ki&#7875;m soát chúng b&#7857;ng atropin <br>
(2 mg, tiêm t&#297;nh m&#7841;ch, sau &#273;ó tiêm b&#7855;p, c&#7913; 2 - 4 gi&#7901;
m&#7897;t l&#7847;n, tùy theo c&#7847;n thi&#7871;t, &#273;&#7875; gi&#7843;m
khó th&#7903;), nh&#432;ng ph&#7843;i tránh quá li&#7873;u atropin.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Nh&#7919;ng tác d&#7909;ng trên c&#417;
x&#432;&#417;ng sau quá li&#7873;u pyridostigmin không d&#7883;u b&#7899;t khi
&#273;i&#7873;u tr&#7883; b&#7857;ng atropin.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Ng&#432;&#7901;i b&#7879;nh ng&#7897; &#273;&#7897;c
do dùng thu&#7889;c kháng cholinesterase không &#273;&#432;&#7907;c dùng
aminophylin, morphin, phenothiazin, thu&#7889;c an th&#7847;n kinh, reserpin,
sucinylcholin, theophylin ho&#7863;c không &#273;&#432;&#7907;c truy&#7873;n m&#7897;t
l&#432;&#7907;ng d&#7883;ch l&#7899;n.<o:p></o:p></span></p>

<p class=chucach align=left style='margin-top:0in;text-align:left;line-height:
150%'><span style='font-family:Verdana'>Thông tin qui ch&#7871;<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'>Thu&#7889;c d&#7841;ng tiêm ph&#7843;i &#273;&#432;&#7907;c
kê &#273;&#417;n và bán theo &#273;&#417;n.<o:p></o:p></span></p>

<p class=MsoNormal align=left style='text-align:left;line-height:150%'><span
style='font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

</div>

</body>


<!-- Mirrored from medicain.net/DUOC THU QUOC GIA/Pyridostigminbromid.htm by HTTrack Website Copier/3.x [XR&CO'2013], Tue, 25 Mar 2014 18:07:09 GMT -->
</html>
